Alpha-Gal Syndrome Whole Blood
About: Fresh Alpha-Gal Syndrome Whole Blood - IRB-consented alpha-gal syndrome whole blood samples collected from donors diagnosed with alpha-gal syndrome (AGS). Ideal for dermatology, immunology, and inflammation-based research.
Fresh Alpha-Gal Syndrome Whole Blood
Alpha-Gal Syndrome Whole Blood is collected from IRB-consented donors with clinically confirmed alpha-gal syndrome (AGS). These fresh samples are ideal for dermatological and immunological research focused on AGS pathogenesis, inflammation, and biomarker discovery.
Product Features
- Fresh whole blood from clinically diagnosed AGS donors
- Custom tubes and anticoagulants available
- Collected and shipped same-day for maximum freshness
- Research Use Only (RUO)
De-identified Donor Data
- Confirmed alpha-gal syndrome (AGS) diagnosis by physician or specialist
- Demographic details: age, sex assigned at birth, ethnicity
- Medical history including allergies and infectious disease status
Applications
- Immunophenotyping of immune cell populations in AGS
- Gene expression and transcriptomic analysis
- Inflammatory marker and cytokine profiling
- Drug response and mechanism-of-action studies
Compliance and Quality
- IRB-approved protocols and electronic informed consent
- HIPAA-compliant data management
- Fast shipping with real-time tracking
Ordering and Customization
Alpha-gal syndrome whole blood is available in a range of standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Whole Blood
Frequently Asked Questions
1 Answer
Collected and shipped same-day – local pickup may be available. For more information, request a quote or contact: LearnMore@sanguinebio.com
1 Answer
YES – The same-day program processes and ships samples on the day of collection, ensuring delivery well within 48 hours for the designated service areas.
Ask a Question
Need a custom Whole Blood cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.